Data / Form D filings / RedHill Biopharma Ltd.
RedHill Biopharma Ltd.: Form D filings
RedHill Biopharma Ltd., a pharmaceuticals company in Tel Aviv, Israel, filed 6 Form D notices with the SEC between 2014 and 2024. The latest, on February 5, 2024, reports $10 million sold of a $10 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 21 HA'ARBA'A STREET, Tel Aviv, Israel, 64739
- Phone
- 972-3-541-3131
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1553846
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | New notice | $10,000,000 | $10,000,000 | 5 | Jan 25, 2024 | sec.gov | |
| Oct 12, 2023 | New notice | $4,043,808 | $4,043,808 | 3 | Sep 28, 2023 | sec.gov | |
| Aug 7, 2023 | New notice | $2,700,000 | $2,700,000 | 1 | Jul 21, 2023 | sec.gov | |
| Nov 22, 2021 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 1 | Nov 8, 2021 | sec.gov |
| Nov 6, 2019 | New notice | $48,300,000 | $48,300,000 | 2 | Oct 22, 2019 | sec.gov | |
| Jan 15, 2014 | New notice | $2,500,020 | $2,500,020 | 1 | Dec 31, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Swenden | Director | |
| Kenneth Reed | Director | |
| Dror Ben-Asher | Executive Officer, Director | |
| Guy Goldberg | Executive Officer | |
| Reza Fathi | Executive Officer | |
| Alla Felder | Director | |
| Gilead Raday | Executive Officer | |
| Ofer Tsimchi | Director | |
| Shmuel Cabilly | Director | |
| Razi Ingber | Executive Officer | |
| Adi Frish | Executive Officer | |
| Rick Scruggs | Executive Officer, Director |
Every Form D from the week of Feb 5, 2024 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RedHill Biopharma Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.